Your Top 100 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis

Adam Brufsky, S.-B. Kim, Zanete Zvirbule, Alexandru E. Eniu, Jeroen Mebis, Joohyuk Sohn and 7 more

Rank
72 of 3,031
Percentile
top 2.4%
Where
Annals of Oncology, 2021
Citations
92

From the 2021 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.